Clinical updates, including trial initiations, enrollment status and data readouts and publications: Lantheus, Oncosec.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bio-Thera, Can-Fite, Corvus, Insmed, Moleculin, Regentree, Teva, United Therapeutics, Zynerba.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Kyowa Kirin, Rani, Ziopharm.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Genetesis, Profusa, Righteye, Venturemed

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aptevo, Autolus, Bayer, Eli Lilly, Exscientia, Incyte, Isofol, Kedrion, Miragen, Orion, Rubius, Sanofi, SQZ, Sumitomo Dainippon.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bluestar Genomics, Polarean

Clinical updates, including trial initiations, enrollment status and data readouts and publications, including Akcea, Delmar, Emmaus, Exopharm, Geneos, Intercept, Orexo, Satsuma, Unum, Vasopharm, Verastem

Clinical updates, including trial initiations, enrollment status and data readouts and publications: On Target Laboratories

Clinical updates, including trial initiations, enrollment status and data readouts and publications, including: Acceleron, Aeterna Zentaris, Bausch Health, Cassava, Clearside, Ikena, Incyte, Syros

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Astellas, Astrazeneca, Beigene, Cstone, Daiichi Sankyo, Epygenix, Hutchison China Meditech, Isofol Medical, Oric